Your trusted source for investing success

Tag: board of directors

Biotech Stocks in 2018


Find out how the market will look this year


Canntab to Commence Trading on CSE on 4/20

Canntab to Commence Trading on CSE on 4/20

Canntab Therapeutics Limited (CSE:PILL) (formerly Telferscot Resources Inc.) (“Canntab” or the “Company”) is pleased to announce that its common shares will commence trading on the Canadian Securities Exchange (the “CSE”) at the opening of the market on Friday, April 20, 2018 under the stock symbol “PILL”.

Hiku Brands and WeedMD to Merge in Transformational Transaction to Create Vertically Integrated Industry Leader

Hiku Brands and WeedMD to Merge in Transformational Transaction to Create Vertically Integrated Industry Leader

Hiku Brands Company Ltd. (“Hiku”) (CSE:HIKU) and WeedMD Inc. (TSXV:WMD, OTC:WDDMF) (FSE:4WE) (“WeedMD”), are pleased to announce that today they have entered into a definitive agreement (the “Arrangement Agreement”) to merge both companies, creating an industry leader (the “Transaction”). The Transaction combines two highly-complementary businesses and creates a unique and market differentiating vertically integrated company. Upon completion of

International Battery Metals Ltd. Confirms Appointment of Dr. John Burba President, CEO, Chairman and Director and Christina Borgese as Director and Executive VP of Research and Development

International Battery Metals Ltd. Confirms Appointment of Dr. John Burba President, CEO, Chairman and Director and Christina Borgese as Director and Executive VP of Research and Development

International Battery Metals Ltd. (CSE:IBAT), is pleased to confirm that it has appointed Dr. John Burba as President, Chief Executive Officer, Chairman and a director of the Company upon completion of the closing of its acquisition of Selective Adsorption Lithium, Inc. as announced on April 13, 2018.

Telson Mining Corporation Releases First Quarter 2018 Pre-Production Results from the Campo Morado Mine

Telson Mining Corporation Releases First Quarter 2018 Pre-Production Results from the Campo Morado Mine

Telson Mining Corporation (TSXV:TSN, OTCBB:SOHFF) (“Telson” or the “Company”) (Shares Issued: 125,726,075) is pleased to present pre-production results of development mining, concentrate production and metallurgical balances for the first three months of 2018 at its 100% owned Campo Morado Mine (“Campo Morado” or the “Project”) located in Guerrero State, Mexico.

PUF Ventures Provides Update to Spin Out Company Cannvas MedTech Inc.

PUF Ventures Provides Update to Spin Out Company Cannvas MedTech Inc.

PUF Ventures Inc. (CSE:PUF, Frankfurt:PU3, OTCPK:PUFXF) (“PUF” or the “Company”), an advanced Access to Cannabis for Medical Purposes Regulations (“ACMPR”) license applicant, is pleased to provide an update regarding its spin out company Cannvas MedTech Inc.’s (“MTEC” or the “Cannvas”) Plan of Arrangement which closed on January 16, 2018.

Uniserve Announces Additional changes to Board

Uniserve Communications Corporation (TSXV:USS) announced that Daniel Frydenlund has agreed to join its Board of Directors as an independent director of the company.

As quoted in the press release:

Mr. Hashim Mitha, who has served on the Board for over four years and was critical in the Company’s prior restructuring, will be

Lite Access Technologies appoints new CFO

Lite Access Technologies (TSXV:LTE), a leader in the use of innovative and proven micro/narrow trenching technologies, alternate methods of payment announced the appointment of Arun Gupta as the Chief Financial Officer of the company.

Gupta who has 15 years of experience in finance will replace Scott MacEachern who will be stepping

Akcea and Ionis Complete Licensing Transaction to Commercialize Inotersen for hATTR

Akcea Therapeutics (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals and Ionis Pharmaceuticals (NASDAQ:IONS) announced the two companies have completed a previously announced transaction licensing the exclusive, worldwide rights from Ionis to Akcea for inotersen and AKCEA-TTR-LRx, formerly IONIS-TTR-LRx.

As quoted in the press release:
Inotersen is under regulatory review in the U.S. and EU

Are You Aware of the FDA's Plans for 2018?

Find out what's going on in our new report
 
Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
Canntab to Commence Trading on CSE on 4/20

URL: https://investingnews.com/daily/resource-investing/agriculture-investing/cannabis-investing/canntab-commence-trading-cse-420/